MedPath

Ilsong Institute

Ilsong Institute logo
🇰🇷South Korea
Ownership
Private
Established
1982-01-01
Employees
251
Market Cap
-
Website
http://www.hallym.ac.kr

Amlodipine and Candesartan Combination Therapy Shows Superior Efficacy in Treating Hypertension

• A Phase III clinical trial demonstrates that a combination of amlodipine and candesartan is more effective than amlodipine alone in reducing diastolic blood pressure in hypertensive patients. • The study, involving Korean patients with essential hypertension, showed significant reductions in both diastolic and systolic blood pressure with the combination therapy. • The fixed-dose combination of amlodipine and candesartan was well-tolerated, with adverse events comparable to those observed with amlodipine monotherapy. • These findings support the use of amlodipine and candesartan combination therapy as an effective treatment option for patients whose hypertension is not adequately controlled by amlodipine alone.
© Copyright 2025. All Rights Reserved by MedPath